Hob Biotech Group Stock Price To Sales
| 688656 Stock | 95.89 8.65 9.92% |
HOB Biotech Group fundamentals help investors to digest information that contributes to HOB Biotech's financial success or failures. It also enables traders to predict the movement of HOB Stock. The fundamental analysis module provides a way to measure HOB Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HOB Biotech stock.
HOB | Price To Sales |
HOB Biotech Group Company Price To Sales Analysis
HOB Biotech's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current HOB Biotech Price To Sales | 14.72 X |
Most of HOB Biotech's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HOB Biotech Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, HOB Biotech Group has a Price To Sales of 14.7162 times. This is 31.23% lower than that of the Health Care Equipment & Supplies sector and 207.87% higher than that of the Health Care industry. The price to sales for all China stocks is 28.86% lower than that of the firm.
HOB Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HOB Biotech's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HOB Biotech could also be used in its relative valuation, which is a method of valuing HOB Biotech by comparing valuation metrics of similar companies.HOB Biotech is currently under evaluation in price to sales category among its peers.
HOB Fundamentals
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.51 B | ||||
| Shares Outstanding | 63.06 M | ||||
| Shares Owned By Insiders | 77.33 % | ||||
| Shares Owned By Institutions | 3.10 % | ||||
| Price To Book | 6.83 X | ||||
| Price To Sales | 14.72 X | ||||
| Revenue | 394.41 M | ||||
| Gross Profit | 254.16 M | ||||
| EBITDA | 78.62 M | ||||
| Net Income | 47.92 M | ||||
| Total Debt | 50.02 M | ||||
| Book Value Per Share | 12.95 X | ||||
| Cash Flow From Operations | 102.69 M | ||||
| Earnings Per Share | 0.56 X | ||||
| Number Of Employees | 550 | ||||
| Beta | -0.63 | ||||
| Market Capitalization | 5.91 B | ||||
| Total Asset | 949.26 M | ||||
| Retained Earnings | 162.13 M | ||||
| Working Capital | 192.46 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 949.26 M |
About HOB Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HOB Biotech Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HOB Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HOB Biotech Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.